Hirasawa, Y.; Satomura, A.; Okada, M.; Utsugi, M.; Ogura, H.; Yanagi, T.; Nakamori, Y.; Takehara, M.; Murakami, K.; Nagao, G.;
et al. Urinary microRNAs as Prognostic Biomarkers for Predicting the Efficacy of Immune Checkpoint Inhibitors in Patients with Urothelial Carcinoma. Cancers 2025, 17, 2640.
https://doi.org/10.3390/cancers17162640
AMA Style
Hirasawa Y, Satomura A, Okada M, Utsugi M, Ogura H, Yanagi T, Nakamori Y, Takehara M, Murakami K, Nagao G,
et al. Urinary microRNAs as Prognostic Biomarkers for Predicting the Efficacy of Immune Checkpoint Inhibitors in Patients with Urothelial Carcinoma. Cancers. 2025; 17(16):2640.
https://doi.org/10.3390/cancers17162640
Chicago/Turabian Style
Hirasawa, Yosuke, Atsushi Satomura, Mitsuo Okada, Mieko Utsugi, Hiroki Ogura, Tsuyoshi Yanagi, Yuta Nakamori, Masayuki Takehara, Kokichi Murakami, Go Nagao,
and et al. 2025. "Urinary microRNAs as Prognostic Biomarkers for Predicting the Efficacy of Immune Checkpoint Inhibitors in Patients with Urothelial Carcinoma" Cancers 17, no. 16: 2640.
https://doi.org/10.3390/cancers17162640
APA Style
Hirasawa, Y., Satomura, A., Okada, M., Utsugi, M., Ogura, H., Yanagi, T., Nakamori, Y., Takehara, M., Murakami, K., Nagao, G., Kashima, T., Satake, N., Ando, Y., Mikami, M., Mizunuma, M., Ichikawa, Y., & Ohno, Y.
(2025). Urinary microRNAs as Prognostic Biomarkers for Predicting the Efficacy of Immune Checkpoint Inhibitors in Patients with Urothelial Carcinoma. Cancers, 17(16), 2640.
https://doi.org/10.3390/cancers17162640
